In other countries
The same active substances on other registers, the same brand first.
- Suprefact DepotBrazil · Sanofi-Aventis Farmacêutica LtdaSame brand
- SUPREFACT 1 mg/ml SOLUCION INYECTABLESpain · 1,050 mg · solución inyectable · Cheplapharm Arzneimittel GmbhSame brand
- SUPREFACT DEPOT 9,45 mg IMPLANTESpain · 9,9 mg · implante · Cheplapharm Arzneimittel GmbhSame brand
- SUPREFACT 100 microgramos/PULSACION SOLUCION PARA PULVERIZACION NASALSpain · 1,050 mg · solucion para pulverizacion nasal · Cheplapharm Arzneimittel GmbhSame brand
- SuprefactItaly · Impianto · Cheplapharm Arzneimittel GMBHSame brand
- Suprefact Depot 3 maanden, implantatiestift 9,45 mgNetherlands · Implantaat · CHEPLAPHARM Arzneimittel GmbHSame brand
- Suprefact Depot 3 maanden, implantatiestift 9,45 mgNetherlands · Implantaat · Medcor Pharmaceuticals B.V.Same brand
- AnyNew Zealand · Inj 1 mg per ml, 5.5 ml vialSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Buserelin
- Strength
- 1 MG / ML
- Dosage form
- Solution
- Route
- Subcutaneous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 30 Dec 1996
- Registration
- DIN 02225166
- Marketing authorisation holder
- Cheplapharm Arzneimittel GMBH
- ATC code
- L02AE01
- Supply
- PRESCRIPTION